| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CVR/CVX130 |
| P698 | PubMed publication ID | 29088374 |
| P2093 | author name string | Hongliang Li | |
| Zan Huang | |||
| Yaxing Zhang | |||
| P2860 | cites work | TAK1 is a ubiquitin-dependent kinase of MKK and IKK | Q24291454 |
| Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3... | Q24297037 | ||
| IFI16 is an innate immune sensor for intracellular DNA | Q24301720 | ||
| IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection | Q24302985 | ||
| Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway | Q24306635 | ||
| Peroxisomes are signaling platforms for antiviral innate immunity | Q24310723 | ||
| ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways | Q24313068 | ||
| MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response | Q24316320 | ||
| Direct activation of protein kinases by unanchored polyubiquitin chains | Q24324679 | ||
| The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens | Q24338114 | ||
| A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation | Q24652200 | ||
| Immunometabolism governs dendritic cell and macrophage function | Q26773266 | ||
| Innate immunity and cardiomyocytes in ischemic heart disease | Q27003911 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination | Q27919663 | ||
| Metabolic reprogramming in macrophages and dendritic cells in innate immunity | Q28080815 | ||
| RIG-I-like receptor regulation in virus infection and immunity | Q28081647 | ||
| Syk kinase-coupled C-type lectin receptors engage protein kinase C-σ to elicit Card9 adaptor-mediated innate immunity | Q28118774 | ||
| Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia | Q28182436 | ||
| Innate immune pattern recognition: a cell biological perspective | Q28255348 | ||
| TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains | Q28278500 | ||
| Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes | Q28366026 | ||
| Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity | Q28504584 | ||
| The receptor NLRP3 is a transcriptional regulator of TH2 differentiation | Q28512758 | ||
| NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis | Q28579741 | ||
| Interferon regulatory factor signalings in cardiometabolic diseases | Q38528480 | ||
| The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses. | Q38800260 | ||
| Inflammasomes: mechanism of assembly, regulation and signalling | Q38862650 | ||
| Post-Translational Modification Control of Innate Immunity | Q38903391 | ||
| Reprogramming Innate Immune Signaling in Cardiometabolic Disease | Q39188744 | ||
| NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective | Q40169693 | ||
| The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. | Q40451032 | ||
| NOD1, a new player in cardiac function and calcium handling. | Q41138874 | ||
| Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice | Q41163325 | ||
| Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy | Q41190651 | ||
| A role for APPL1 in TLR3/4-dependent TBK1 and IKKε activation in macrophages. | Q41424373 | ||
| Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart | Q41518012 | ||
| Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension | Q41630351 | ||
| Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation | Q41862491 | ||
| Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension | Q42229127 | ||
| Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis | Q42269363 | ||
| Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial-mesenchymal transition | Q42481440 | ||
| Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. | Q42732446 | ||
| The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β. | Q42832204 | ||
| Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. | Q44693877 | ||
| Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction | Q44731224 | ||
| Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse | Q44980873 | ||
| Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse | Q45027851 | ||
| Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo | Q45253902 | ||
| Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin | Q45847502 | ||
| NF-kappaB activation is required for adaptive cardiac hypertrophy. | Q45924674 | ||
| Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling. | Q45932209 | ||
| Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload | Q46557239 | ||
| Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension | Q46570302 | ||
| Inhibitory Effects of Hydrogen on Proliferation and Migration of Vascular Smooth Muscle Cells via Down-Regulation of Mitogen/Activated Protein Kinase and Ezrin-Radixin-Moesin Signaling Pathways | Q46596209 | ||
| Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice | Q47200145 | ||
| NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload | Q47745538 | ||
| NOD2 contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and inflammation. | Q50204712 | ||
| Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury. | Q51061341 | ||
| Interferon regulatory factor 1 attenuates vascular remodeling; roles of angiotensin II type 2 receptor. | Q51532773 | ||
| Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury. | Q53358508 | ||
| TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo. | Q53372809 | ||
| Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse. | Q53395166 | ||
| Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression. | Q53670996 | ||
| Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. | Q53791702 | ||
| NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice. | Q54389267 | ||
| Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance. | Q54403182 | ||
| Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells. | Q54719546 | ||
| Activation of NOD1 by DAP contributes to myocardial ischemia/reperfusion injury via multiple signaling pathways. | Q55068540 | ||
| IRF4 is a key thermogenic transcriptional partner of PGC-1α | Q28590968 | ||
| The mammalian PYHIN gene family: phylogeny, evolution and expression | Q28727434 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response | Q29617083 | ||
| Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO | Q29618712 | ||
| Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected] | Q29618714 | ||
| NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis | Q33478396 | ||
| IRF4 is a novel mediator for neuronal survival in ischaemic stroke | Q33580173 | ||
| MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. | Q33648129 | ||
| Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. | Q33809396 | ||
| Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines | Q33861276 | ||
| The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart | Q34022068 | ||
| Brain microglial cytokines in neurogenic hypertension | Q34089804 | ||
| The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes | Q34248415 | ||
| Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure | Q34270939 | ||
| Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling | Q34357976 | ||
| Interferon regulatory factor 9 is critical for neointima formation following vascular injury | Q34446578 | ||
| IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis | Q34562186 | ||
| Essential role of Smad3 in angiotensin II-induced vascular fibrosis | Q34575283 | ||
| Transcriptional control of adipose lipid handling by IRF4 | Q34713714 | ||
| Cardiac plasticity | Q34764732 | ||
| Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling | Q34995991 | ||
| Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy | Q35001980 | ||
| Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload | Q35002059 | ||
| The immune system and hypertension. | Q35038155 | ||
| Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation | Q35070759 | ||
| Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension | Q35110074 | ||
| Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1 | Q35135046 | ||
| The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. | Q35621283 | ||
| Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus. | Q35707198 | ||
| Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. | Q35766938 | ||
| Signaling by myeloid C-type lectin receptors in immunity and homeostasis | Q35779708 | ||
| Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse | Q35847003 | ||
| MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. | Q35892464 | ||
| Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling | Q35926510 | ||
| Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt | Q35929017 | ||
| Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene Expression. | Q35956355 | ||
| Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy | Q36110312 | ||
| TRAF1 is a key mediator for hepatic ischemia/reperfusion injury | Q36291138 | ||
| The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases | Q36342106 | ||
| CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling | Q36456832 | ||
| Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling | Q36591276 | ||
| Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury | Q36596636 | ||
| Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload | Q36830845 | ||
| HDAC-dependent ventricular remodeling | Q36945016 | ||
| The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. | Q36974840 | ||
| Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy | Q37073978 | ||
| Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice | Q37078467 | ||
| The IRF family transcription factors in immunity and oncogenesis | Q37096072 | ||
| Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling | Q37234808 | ||
| Pathological ventricular remodeling: mechanisms: part 1 of 2 | Q37241166 | ||
| Pathological ventricular remodeling: therapies: part 2 of 2. | Q37312758 | ||
| Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection | Q37331568 | ||
| Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin. | Q37546984 | ||
| Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury | Q37648514 | ||
| Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury | Q37648557 | ||
| Interleukin-18 mediates interleukin-1-induced cardiac dysfunction | Q37656103 | ||
| A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse | Q37692892 | ||
| Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy | Q37698309 | ||
| In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. | Q37710952 | ||
| Innate immune signaling in cardiac ischemia | Q37859249 | ||
| The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls | Q37870040 | ||
| The innate immune response in reperfused myocardium | Q37977824 | ||
| C-type lectin receptors orchestrate antifungal immunity | Q38036520 | ||
| Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease | Q38210113 | ||
| Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors | Q38258737 | ||
| Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis | Q38293912 | ||
| NOD-like receptors: versatile cytosolic sentinels. | Q38300466 | ||
| Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance | Q38315303 | ||
| In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction | Q38343941 | ||
| P433 | issue | 13 | |
| P304 | page(s) | 1538-1550 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Insights into innate immune signalling in controlling cardiac remodelling. | |
| P478 | volume | 113 |
| Q60953194 | A20 alleviates the vascular remodeling induced by homocysteine |
| Q50089724 | Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets. |
| Q64226786 | Common risk factors for heart failure and cancer |
| Q92799537 | H2 Protects Against Lipopolysaccharide-Induced Cardiac Dysfunction via Blocking TLR4-Mediated Cytokines Expression |
| Q98226408 | Innate Immune Receptors, Key Actors in Cardiovascular Diseases |
| Q58555583 | Th1 type immune responses to Porphyromonas gingivalis antigens exacerbate Angiotensin II dependent hypertension and vascular dysfunction |
| Q97544688 | The Role of Biomarkers in Cardio-Oncology |
| Q98224256 | The Roles of Noncardiomyocytes in Cardiac Remodeling |
Search more.